393 related articles for article (PubMed ID: 30458730)
1. Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population.
Zhou T; Li HY; Zhong H; Zhong Z
BMC Med Genet; 2018 Nov; 19(1):201. PubMed ID: 30458730
[TBL] [Abstract][Full Text] [Related]
2. Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: A PRISMA-compliant systematic review and meta-analysis.
Qiao YC; Chen YL; Pan YH; Ling W; Tian F; Zhang XX; Zhao HL
Medicine (Baltimore); 2017 Apr; 96(15):e6583. PubMed ID: 28403088
[TBL] [Abstract][Full Text] [Related]
3. Association Between Transforming Growth Factor-β1 T869C Gene Polymorphism and Diabetic Nephropathy: A Meta-Analysis in the Chinese Population.
Zhou D; Mou X; Liu K; Liu W; Xu Y; Zhou D
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307180
[TBL] [Abstract][Full Text] [Related]
4. Association of transforming growth factor-β1 T869C gene polymorphism with diabetic nephropathy risk.
Zhou TB; Jiang ZP; Qin YH; Drummen GP
Nephrology (Carlton); 2014 Feb; 19(2):107-15. PubMed ID: 24428217
[TBL] [Abstract][Full Text] [Related]
5. Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism.
Mou X; Liu WH; Zhou DY; Liu YH; Hu YB; Ma GL; Shou CM; Chen JW; Zhao JX
Chin J Integr Med; 2011 Sep; 17(9):680-4. PubMed ID: 21910069
[TBL] [Abstract][Full Text] [Related]
6. Associations Between Genetic Polymorphisms in the
Luo Y; Luo J; Peng H
Genet Test Mol Biomarkers; 2019 Sep; 23(9):644-651. PubMed ID: 31524543
[No Abstract] [Full Text] [Related]
7. Forkhead box P3 gene polymorphisms predispose to type 2 diabetes and diabetic nephropathy in the Han Chinese populations: a genetic-association and gender-based evaluation study.
Wang X; Liu Z; Zhang S; Yang Y; Wu X; Liu X
Hereditas; 2023 Jan; 160(1):3. PubMed ID: 36717877
[TBL] [Abstract][Full Text] [Related]
8. Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.
Wong TY; Poon P; Chow KM; Szeto CC; Cheung MK; Li PK
Kidney Int; 2003 May; 63(5):1831-5. PubMed ID: 12675860
[TBL] [Abstract][Full Text] [Related]
9. The transforming growth factor-β1 (TGF-β1) gene polymorphisms (TGF-β1 T869C and TGF-β1 T29C) and susceptibility to postmenopausal osteoporosis: a meta-analysis.
Sun J; Zhang C; Xu L; Yang M; Yang H
Medicine (Baltimore); 2015 Jan; 94(4):e461. PubMed ID: 25634187
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.
El-Sherbini SM; Shahen SM; Mosaad YM; Abdelgawad MS; Talaat RM
Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):330-8. PubMed ID: 23399816
[TBL] [Abstract][Full Text] [Related]
11. Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis.
Cui ZH; Lu XT; Xiao KL; Chen Y; Li HQ
Curr Med Sci; 2019 Apr; 39(2):250-258. PubMed ID: 31016518
[TBL] [Abstract][Full Text] [Related]
12. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
[TBL] [Abstract][Full Text] [Related]
13. Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.
Jia H; Yu L; Gao B; Ji Q
Endocrine; 2011 Dec; 40(3):372-8. PubMed ID: 21725704
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the association of G915C, G800A, C509T gene polymorphism of transforming growth factor-β1 with diabetic nephropathy risk.
Zhang J; Guan YL; Xiao Y; Zhang XW
Ren Fail; 2014 Mar; 36(2):321-6. PubMed ID: 24060183
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
[TBL] [Abstract][Full Text] [Related]
16. Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.
Peng L; Li P; Chen J; Yan K; Huo F; Han L; Li C; Tan S; Jiang X
PLoS One; 2013; 8(7):e67738. PubMed ID: 23861796
[TBL] [Abstract][Full Text] [Related]
17. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
Zhou TB; Guo XF; Yin SS
J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes.
Buraczynska M; Baranowicz-Gaszczyk I; Borowicz E; Ksiazek A
Nephron Physiol; 2007; 106(4):p69-75. PubMed ID: 17622752
[TBL] [Abstract][Full Text] [Related]
20. Association of ApoE gene with type 2 diabetic nephropathy in a Chinese population: a meta-analysis of case-control studies.
Zhang C; Li S; Zhang X; Liu H; Luo Y
Ann Endocrinol (Paris); 2015 Oct; 76(5):601-13. PubMed ID: 25669588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
